- Volume 26 - Issue 11 - November 2013
- 2161 reads
- 0 comments
Lowell Weil Jr., DPM, MBA, FACFAS, cites several advantages of ESWT for plantar fasciitis, including no complications or risks, a large body of randomized controlled trials in the therapy’s favor, no pain after treatment and a quick return to activity. On the downside, he notes shockwave can be expensive and is typically not covered by insurance.
As for autologous conditioned plasma, Dr. Weil says although it is less expensive than shockwave, there are minimal studies showing the treatment’s benefits and many studies indicating that autologous conditioned plasma has no benefits. Autologous conditioned plasma is also slightly invasive and can cause post-procedural discomfort, according to Dr. Weil, the President and Fellowship Director of the Weil Foot and Ankle Institute in Illinois.